Related Experiment Videos
[Magnesium and myocardial infarction. Brazilian aspects]
1Clínicia Geral do Hospital das Clínicas, Faculdade da Universidade de São Paulo.
Revista Do Hospital Das Clinicas
|June 18, 1998
Summary
Magnesium (Mg) deficiency is common in Brazil. Supplementing magnesium sulfate in acute myocardial infarction patients reduced arrhythmias, mortality, and infarct size, though studies had small sample sizes.
Area of Science:
- Cardiology
- Biochemistry
- Public Health
Context:
- Brazil faces widespread magnesium deficiency, impacting public health.
- Low urinary magnesium levels are prevalent in the general population.
- Acute myocardial infarction (AMI) is a critical cardiovascular event.
Purpose:
- To investigate the behavior of plasma and lymphocytic magnesium during AMI.
- To evaluate the therapeutic effect of magnesium sulfate (MgSO4) infusion in AMI patients.
- To assess the impact of MgSO4 on arrhythmias, mortality, and infarct size.
Summary:
- Plasma and lymphocytic magnesium levels significantly decrease during the initial three days of uncomplicated AMI, showing a progressive rise but not reaching normal levels.
- Intravenous MgSO4 infusion (4g over 3 days in São Paulo, 10g in 24 hours in Bahia) demonstrated a reduction in arrhythmias, mortality, and infarct size.
- Despite promising results, the protective role of magnesium in AMI requires further investigation due to small sample sizes in existing studies.
Impact:
- Highlights the potential of magnesium as a therapeutic agent in managing acute myocardial infarction.
- Underscores the need for larger, well-controlled trials to confirm magnesium's efficacy and optimal dosage.
- Informs public health strategies regarding magnesium supplementation in populations with deficiency and cardiovascular risks.